HUP0000122A2 - Nyújtott felszabadulású ionos konjugátumok - Google Patents

Nyújtott felszabadulású ionos konjugátumok

Info

Publication number
HUP0000122A2
HUP0000122A2 HU0000122A HUP0000122A HUP0000122A2 HU P0000122 A2 HUP0000122 A2 HU P0000122A2 HU 0000122 A HU0000122 A HU 0000122A HU P0000122 A HUP0000122 A HU P0000122A HU P0000122 A2 HUP0000122 A2 HU P0000122A2
Authority
HU
Hungary
Prior art keywords
sustained release
ionic conjugate
release ionic
tube core
core
Prior art date
Application number
HU0000122A
Other languages
English (en)
Inventor
Francis Ignatious
Thomas Ciarán Loughman
Shalaby W. Shalaby
Franck Jean-Claude Touraud
Original Assignee
Kinerton Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kinerton Limited filed Critical Kinerton Limited
Publication of HUP0000122A2 publication Critical patent/HUP0000122A2/hu
Publication of HUP0000122A3 publication Critical patent/HUP0000122A3/hu
Publication of HU224036B1 publication Critical patent/HU224036B1/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593Polyesters, e.g. PLGA or polylactide-co-glycolide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]
    • Y10T428/2985Solid-walled microcapsule from synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Saccharide Compounds (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Steroid Compounds (AREA)
  • Lubricants (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Detergent Compositions (AREA)

Abstract

A találmány szabad karbőxilcsőpőrtőt tartalmazó biőlógiailagdegradálható pőlimert és szabad aminőcsőpőrtőt tartalmazó hatóanyagőtegymással iőnős kötéssel kapcsőlódva tartalmazó nyújtőttfelszabadűlású iőnős gömböcskékké alakítására vőnatkőzik. A találmánykiterjed biőlógiailag degradálható pőlimerekre és az ezeket tartalmazómikrőrészecskékre is. ŕ
HU0000122A 1996-04-23 1997-04-22 Nyújtott felszabadulású ionos konjugátumok HU224036B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE960308A IE960308A1 (en) 1996-04-23 1996-04-23 Sustained release ionic conjugate
PCT/IE1997/000030 WO1997039738A2 (en) 1996-04-23 1997-04-22 Sustained release ionic conjugate

Publications (3)

Publication Number Publication Date
HUP0000122A2 true HUP0000122A2 (hu) 2000-06-28
HUP0000122A3 HUP0000122A3 (en) 2000-08-28
HU224036B1 HU224036B1 (hu) 2005-05-30

Family

ID=11041150

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000122A HU224036B1 (hu) 1996-04-23 1997-04-22 Nyújtott felszabadulású ionos konjugátumok

Country Status (28)

Country Link
US (3) US6911218B2 (hu)
EP (1) EP0904062B1 (hu)
JP (2) JP3390177B2 (hu)
KR (1) KR20000010621A (hu)
CN (2) CN1186012C (hu)
AT (1) ATE245970T1 (hu)
BG (1) BG102947A (hu)
BR (1) BR9708818A (hu)
CA (1) CA2252826A1 (hu)
CZ (2) CZ293965B6 (hu)
DE (1) DE69723833T2 (hu)
DK (1) DK0904062T3 (hu)
EE (1) EE9800349A (hu)
ES (1) ES2200172T3 (hu)
HK (1) HK1018748A1 (hu)
HU (1) HU224036B1 (hu)
IE (1) IE960308A1 (hu)
IL (1) IL126619A (hu)
IS (1) IS4869A (hu)
NO (1) NO984924L (hu)
NZ (1) NZ332893A (hu)
PL (2) PL189319B1 (hu)
PT (1) PT904062E (hu)
RU (1) RU2173137C2 (hu)
SK (1) SK145598A3 (hu)
TR (1) TR199802125T2 (hu)
WO (1) WO1997039738A2 (hu)
YU (1) YU46598A (hu)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221958B1 (en) * 1993-01-06 2001-04-24 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
US6413539B1 (en) * 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
IE960308A1 (en) * 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
US6867181B1 (en) 1997-06-02 2005-03-15 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
US6468519B1 (en) 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
US7122615B1 (en) 1998-09-10 2006-10-17 Rutgers, The State University Of New Jersey Polyanhydrides with therapeutically useful degradation products
US6486214B1 (en) 1997-09-10 2002-11-26 Rutgers, The State University Of New Jersey Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
EP1240896A3 (en) * 1998-07-23 2003-03-26 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Encapsulation of water soluble peptides
IES990700A2 (en) * 1999-08-18 2001-08-22 Kinerton Ltd Process to make a sustained release formulation
NZ526127A (en) * 1999-08-18 2005-02-25 Sod Conseils Rech Applic Use of a somatostatin analog in the manufacture of a medicament
US7109166B1 (en) 1999-08-18 2006-09-19 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Sustained release formulation of a peptide
EP1348444B1 (en) * 1999-08-18 2006-04-12 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Sustained release formulation of a peptide complexed with a polymer
US20040038948A1 (en) 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
US6685928B2 (en) 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
KR100452752B1 (ko) * 2000-04-18 2004-10-12 주식회사 펩트론 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제
AU2001278055A1 (en) 2000-07-27 2002-02-13 Rutgers, The State University Therapeutic polyesters and polyamides
US6602915B2 (en) 2000-07-27 2003-08-05 Rutgers, The State University Of New Jersey Therapeutic azo-compounds for drug delivery
KR20040108651A (ko) 2002-02-07 2004-12-24 루트거스, 더 스테이트 유니버시티 오브 뉴 저지 치료용 폴리에스테르 및 폴리아미드
WO2003090807A1 (en) * 2002-04-24 2003-11-06 Poly-Med, Inc. Multifaceted endovascular stent coating for preventing restenosis
AU2003289178A1 (en) * 2002-12-04 2004-06-23 Yasuo Hatate Agricultural-chemical microcapsule preparation made by oil/oil liquid drying and process for producing the same
MX2007004676A (es) 2004-10-27 2007-11-14 Univ Denver Analogos de la hormona adrenocorticotropica y metodos relacionados.
EP1951260A4 (en) 2005-10-21 2009-11-11 Bezwada Biomedical Llc FUNCTIONALIZED PHENOLIC COMPOUNDS AND POURABLE ARTICLES THEREOF
US8007526B2 (en) 2005-12-01 2011-08-30 Bezwada Biomedical, Llc Difunctionalized aromatic compounds and polymers therefrom
EP2102144A4 (en) 2006-09-13 2011-03-23 Univ Rutgers ACTIVE SUBSTANCES AND THEIR OLIGOMERS AND POLYMERS
EP2148691B1 (en) 2007-02-05 2015-05-20 Apellis Pharmaceuticals, Inc. Compstatin analogues for use in the treatment of inflammatory conditions of the respiratory system
AR066677A1 (es) 2007-05-24 2009-09-02 Novartis Ag Formulacion de pasireotida. composicion farmaceutica para liberacion prolongada. microparticulas.
US8217134B2 (en) 2007-08-30 2012-07-10 Bezwada Biomedical, Llc Controlled release of biologically active compounds
US8048980B2 (en) 2007-09-17 2011-11-01 Bezwada Biomedical, Llc Hydrolysable linkers and cross-linkers for absorbable polymers
KR101224004B1 (ko) * 2009-12-29 2013-01-22 주식회사 삼양바이오팜 단백질, 폴리펩타이드 또는 펩타이드 약물 전달용 고분자 및 그 제조방법, 및 단백질, 폴리펩타이드 또는 펩타이드 약물의 서방형 조성물 및 그 제조 방법
US9144579B2 (en) 2012-08-17 2015-09-29 Rutgers, The State University Of New Jersey Polyesters and methods of use thereof
US20140120057A1 (en) 2012-10-25 2014-05-01 Rutgers, The State University Of New Jersey Polymers and methods thereof for wound healing
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair
US9862672B2 (en) 2013-05-29 2018-01-09 Rutgers, The State University Of New Jersey Antioxidant-based poly(anhydride-esters)
WO2015191742A1 (en) 2014-06-13 2015-12-17 Rutgers, The State University Of New Jersey Process and intermediates for preparing poly(anhydride-esters)
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)
US10543162B2 (en) 2015-04-10 2020-01-28 Rutgers, The State University Of New Jersey Kojic acid polymers

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS5933214A (ja) 1982-08-19 1984-02-23 Mitsui Toatsu Chem Inc 微小球に製剤された制ガン剤の製造方法
DE3936191C2 (de) 1989-10-31 1996-10-17 Boehringer Ingelheim Kg Neue Copolymere aus Milchsäure und Weinsäure, ihre Herstellung sowie ihre Verwendung
MY107937A (en) 1990-02-13 1996-06-29 Takeda Chemical Industries Ltd Prolonged release microcapsules.
JP2653255B2 (ja) 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
DE4034334A1 (de) 1990-10-29 1992-04-30 Basf Ag Verwendung von weinsaeure einkondensiert enthaltenden polyestern als waschmittelzusatz, verfahren zur herstellung der polyester und polyester aus weinsaeure und tetracarbonsaeuren
ZA93929B (en) * 1992-02-18 1993-09-10 Akzo Nv A process for the preparation of biologically active materialcontaining polymeric microcapsules.
WO1993017668A1 (en) * 1992-03-12 1993-09-16 Alkermes Controlled Therapeutics, Inc. Controlled release acth containing microspheres
CA2144310A1 (en) 1992-09-22 1994-03-31 Richard G. Sinclair Degradation control of environmentally degradable disposable materials
US6221958B1 (en) * 1993-01-06 2001-04-24 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
ES2196023T3 (es) * 1993-01-06 2003-12-16 Kinerton Ltd Conjugados moleculares ionicos de poliesteres biodegradables y polipeptidos bioactivos.
GB9310030D0 (en) 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
IE960308A1 (en) * 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
EP1479707A3 (en) 1996-04-23 2005-05-18 Ipsen Manufacturing Ireland Limited Biodegradable polyesters and method for their preparation

Also Published As

Publication number Publication date
IL126619A (en) 2003-07-31
CN1626243A (zh) 2005-06-15
US20060121120A1 (en) 2006-06-08
US7179490B2 (en) 2007-02-20
CZ293965B6 (cs) 2004-08-18
ES2200172T3 (es) 2004-03-01
DE69723833D1 (de) 2003-09-04
BG102947A (en) 1999-08-31
HUP0000122A3 (en) 2000-08-28
NO984924L (no) 1998-12-21
AU2575197A (en) 1997-11-12
CN1186012C (zh) 2005-01-26
US6911218B2 (en) 2005-06-28
JPH11508609A (ja) 1999-07-27
PL189319B1 (pl) 2005-07-29
US20050074492A1 (en) 2005-04-07
EP0904062B1 (en) 2003-07-30
US20020041893A1 (en) 2002-04-11
US7026431B2 (en) 2006-04-11
NO984924D0 (no) 1998-10-22
ATE245970T1 (de) 2003-08-15
WO1997039738A2 (en) 1997-10-30
IL126619A0 (en) 1999-08-17
NZ332893A (en) 2000-03-27
TR199802125T2 (xx) 1999-01-18
WO1997039738A3 (en) 1997-11-27
AU721433B2 (en) 2000-07-06
DE69723833T2 (de) 2004-05-13
CA2252826A1 (en) 1997-10-30
EE9800349A (et) 1999-04-15
RU2173137C2 (ru) 2001-09-10
JP2003026606A (ja) 2003-01-29
CZ293822B6 (cs) 2004-08-18
SK145598A3 (en) 1999-03-12
CN1216465A (zh) 1999-05-12
PL329606A1 (en) 1999-03-29
PT904062E (pt) 2003-11-28
JP3390177B2 (ja) 2003-03-24
YU46598A (sh) 1999-09-27
EP0904062A2 (en) 1999-03-31
IE960308A1 (en) 1997-11-05
HU224036B1 (hu) 2005-05-30
HK1018748A1 (en) 2000-01-07
PL188517B1 (pl) 2005-02-28
BR9708818A (pt) 2000-01-04
CZ329998A3 (cs) 1999-02-17
DK0904062T3 (da) 2003-10-20
KR20000010621A (ko) 2000-02-25
IS4869A (is) 1998-10-16

Similar Documents

Publication Publication Date Title
HUP0000122A2 (hu) Nyújtott felszabadulású ionos konjugátumok
DK0729357T3 (da) Mikroindkapslede 1,2-benzazoler
ATE258043T1 (de) Langsam freisetzende zubereitung für bioaktive substanz mit einer sauren gruppe
WO2003000237A8 (en) Biodegradable polymer coompositions
ATE258786T1 (de) Mit apatit beschichtete feste zusammensetzung
PT839525E (pt) Preparacao de libertacao prolongada
EP0880973A3 (en) Adhesive composition or structure
DE69831074D1 (de) Superporöse hydrogelverbundstoffe mit schneller quellung,hoher mechanischer festigkeit und superabsorbierenden eigenschaften
NO964410D0 (no) Matriks-pelleter med langsom frigiving, samt fremstilling av disse
DE69903351T2 (de) Vernetzte hyaluronsäure und ihre medizinischen verwendungen
ES2118251T3 (es) Preparaciones de microparticulas a base de copolimeros biologicamente degradables.
NO942396L (no) Preparat med vedvarende frigiving av anti-endotelin substans
ATE357260T1 (de) Lactongruppen tragende absorbierbare polymere
ATE270087T1 (de) Haarkonditionierende zusammensetzung enthaltend ein carbonsäure/carboxylat-copolymer und ein amphoteres konditionierungsmittel
AR022647A1 (es) Proceso para preparar una formulacion de liberacion sostenida
MX9707310A (es) Microesferas novedosas de poli-(lactida/glicolida) de liberacion sostenida sin estallamiento.

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20050322

MM4A Lapse of definitive patent protection due to non-payment of fees